The anti-tumor efficacy and immune effects of combining of ceralasertib, an oral ATR kinase inhibitor, with imipridones, in prostate cancer treatment in vitro and in vivo

被引：0
|
作者：
Xia, Yutong Linda
Zhang, Leiqing
Ghandali, Maryam
Schwermann, Maximilian P.
El-Deiry, Wafik
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5559
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The anti-tumor efficacy of combining oral ATR kinase inhibitor ceralasertib with TIC10/ONC201, an oral Akt/ERK inhibitor, TRAIL pathway and integrated stress response inducer, in prostate cancer treatment
    Xia, Yutong
    Schwermann, Maximilian P.
    George, Andrew
    Ochsner, Anna
    Carneiro, Benedito A.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Effects of antibiotics on the anti-tumor efficacy of immune checkpoint inhibitor therapy
    Nie, Fangfang
    Guo, Jungang
    Pan, Jiayi
    Guo, Zhaojiao
    Wang, Chun
    Yan, Jun
    Ma, Weina
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (02): : 790 - 799
  • [3] In vitro and in vivo anti-tumor activities of SG135 in prostate cancer
    Yang, H. O.
    Yang, E. M.
    Kim, S. N.
    Yoo, J. H.
    Kim, Y. K.
    EJC SUPPLEMENTS, 2006, 4 (12): : 41 - 42
  • [4] Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo
    Sungwan, Prin
    Kidoikhammouan, Sonexai
    Thonsri, Unchalee
    Saengboonmee, Charupong
    Wongkham, Sopit
    Okada, Seiji
    Seubwai, Wunchana
    IN VIVO, 2024, 38 (05): : 2284 - 2293
  • [5] The Glutaminase Inhibitor Compound 968 Exhibits Potent In vitro and In vivo Anti-tumor Effects in Endometrial Cancer
    Guo, Hui
    Li, Wanhu
    Pan, Guoyou
    Wang, Cong
    Li, Dapeng
    Liu, Naifu
    Sheng, Xiugui
    Yuan, Lingqin
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (02) : 210 - 221
  • [6] Preclinical development of a novel oral multitargeted kinase inhibitor with potent in vivo anti-tumor activity
    Beaulieu, Normand
    Dupont, Isabelle
    Hannah Nguyen
    Carole, Beaulieu
    Ste-Croix, Helene
    Robert, Marie-France
    Lefebvre, Sylvain
    Lu, Ai Hua
    Dubay, Maria
    Rahil, Gabi
    Wang, James
    Mannion, Michael
    Raeppel, Stephane
    Saavedra, Oscar
    Claridge, Stephen
    Isakovic, Lubo
    Zhan, Lijie
    Gaudette, Frederic
    Zhou, Nancy
    Nantel, Miguel
    Raeppel, Franck
    Vaisburg, Arkadii
    Besterman, Jeffrey
    Maroun, Christiane
    CANCER RESEARCH, 2009, 69
  • [7] Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo
    Chen, Yuan-Wu
    Lin, Gu-Jiun
    Chia, Wei-Tso
    Lin, Chih-Kung
    Chuang, Yi-Ping
    Sytwu, Huey-Kang
    ORAL ONCOLOGY, 2009, 45 (07) : 562 - 568
  • [8] Anti-tumor effects of a folateimmunoglobulin conjugate are enhanced by cytokine treatment in vitro and in vivo
    Jaime-Ramirez, Cristina
    Kondadasula, SriVidya
    Jones, Natalie B.
    Mani, Aruna
    Roda, Julie
    Karpa, Volodymyr
    Lu, Yanhui
    Li, Hong
    Zhang, Xiaoli
    Jarjoura, David
    Lee, Robert J.
    Carson, William E.
    CANCER RESEARCH, 2011, 71
  • [9] Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo
    Han, S. -Y.
    Lee, C. O.
    Ahn, S. -H.
    Cha, H. -J.
    Cho, S. Y.
    Ha, J. Du.
    Ryu, J. W.
    Jung, H.
    Kim, H. R.
    Koh, J. S.
    Lee, J.
    FEBS JOURNAL, 2011, 278 : 210 - 210
  • [10] Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo
    Sun-Young Han
    Chong Ock Lee
    Sung-Hoon Ahn
    Mi-Ok Lee
    So-Young Kang
    Hyuk-Jin Cha
    Sung Yun Cho
    Jae Du Ha
    Jae Wook Ryu
    Heejung Jung
    Hyoung Rae Kim
    Jong Sung Koh
    Jongkook Lee
    Investigational New Drugs, 2012, 30 : 518 - 523
12345